A A
RSS

Largest Trial So Far in Mesothelioma Disappoints – Medscape

Thu, Sep 29, 2011

Alimta News


Largest Trial So Far in Mesothelioma Disappoints
Medscape
The phase 3 study was conducted in 660 patients with malignant pleural mesothelioma who had progressed after 1 or 2 systemic therapies, including pemetrexed (Alimta) and cisplatin. All patients received best supportive care, and were randomized to ...

Comments are closed.